Arcturus’ COVID Vaccine Moves to Phase 2 Trial in Singapore
On December 28th, Arcturus Therapeutics announced that it had received authorization from the Singapore Health Sciences Authority to begin Phase 2 clinical trials of their vaccine candidate, ARCT-021, against COVID-19. …
Read More